Dr Mike Fay is a cancer researcher and clinical oncologist, with Genesis Care Newcastle. Prior to 2014 he was a Radiation Oncologist and Director of Cancer Research for Royal Brisbane and Women’s Hospital. Until 2007 he was a staff specialist in Radiation Oncology at the Peter MacCallum Cancer Institute in Melbourne. Over his career he has worked or trained in the US, Germany, the UK and New Zealand, with key roles as a clinician, researcher and hospital research leader.

He is currently Chair of both the Genesis Care NSW Radiation Oncology Research committee and the National Theranostics Research Committee and sits on the the Research Leaders Forum. He introduced Genesis Care to the CSIRO theranostics development team culminating in a recently funded $5.1 million new drug development program. He also leads radiobiology and brain cancer research at the Hunter Medical Research Institute in a part time academic role with leading publications in international journals. He has academic appointments at the Universities of Queensland (UQ) and Newcastle to leverage research and strategic opportunities in the cancer space. He has been awarded over $5 million in research funding; including from bodies such as the NHMRC and the ACRF. He is a member of the Scientific Committee of the Mark Hughes Foundation – a charity supporting brain cancer research.

He has dual fellowships in Medical Oncology (FRACP) and Radiation Oncology (FRANZCR) and his PhD in theranostics and neuro-Imaging is under examination at the University of Queensland. He has a strong interest in the Australian biotech sector and is a keen advocate for the introduction of disruptive technologies in Oncology.